Moreover, PVN CRH activity is also a driver of increased SNS tone [169,170,171,172,173,174,175] (adding to the insulin resistance potentiation of hypercortisolemia) that, in turn, can potentiate increases in plasma corticosteroid levels [176]. The gene discussed is CRH; the disease is adrenal gland hyperfunction.